Fibroblast growth factor receptor–3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase–Akt pathway
- 1 May 2010
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 112 (5) , 934-939
Abstract
Object: Fibroblast growth factor receptors (FGFRs)–1, –2, and –3 are expressed in the developing brain and may participate in CNS neoplasia. Fibroblast growth receptor–3 has not been demonstrated in the human CNS or its tumors. Nonetheless, it has been implicated in the pathogenesis of several other forms of neoplasia. Methods: Twenty-four human meningiomas were evaluated using Western blot analysis for expression of FGFR3, its ligand acidic FGF, and concomitant phosphorylation/activation of p44/42 mitogen-activated protein kinase (MAPK), Akt, and STAT3. Mutations in exons 7 and 10 of the FGFR3 gene were analyzed by polymerase chain reaction in 10 meningiomas. Primary meningioma cells cultured from 10 human meningiomas were also treated with acidic FGF and evaluated for cell proliferation or activation/phosphorylation of p44/42 MAPK, Akt, and STAT3. Results: Immunoblotting demonstrated the presence of FGFR3 in 12 (71%) of 17 primarily fibroblastic and transitional WHO Grade I meningiomas. The FGFR3 was detected in 4 (80%) of 5 WHO Grade II, and 2 of 2 Grade III tumors. Acidic FGF was detected in 3 (18%) of 17 Grade I, 1 (20%) of 5 Grade II, and 1 (50%) of 2 Grade III meningiomas. In WHO Grade I meningiomas, 3 of 6 tumors with no detectable FGFR3 had no detectable p-STAT3. In WHO Grades II and III meningiomas, FGFR3 expression was associated with p-STAT3, p-Akt, and p-p44/42 MAPK expression. No mutations were demonstrated in exons 7 or 10 by polymerase chain reaction in any meningioma. Treatment with acidic FGF, a ligand for FGFR3, stimulated meningioma cell proliferation and activation of Akt and STAT3 in primary meningioma cell cultures. Conclusions: These findings suggest that FGFR3 and acidic FGF are expressed in adult human leptomeninges as well as WHO Grades I and II meningiomas. Fibroblast growth factor receptor–3 activation stimulates meningioma cell proliferation by activation of the phosphoinositide 3 kinase–Akt-PRAS40-mTOR and STAT3 pathways.Keywords
This publication has 32 references indexed in Scilit:
- Targeting the AKT protein kinase for cancer chemopreventionMolecular Cancer Therapeutics, 2007
- Mitogenic Signal Transduction Pathways in Meningiomas: Novel Targets for Meningioma Chemotherapy?Journal of Neuropathology & Experimental Neurology, 2005
- Cellular signaling by fibroblast growth factor receptorsCytokine & Growth Factor Reviews, 2005
- Evidence for phosphatidylinositol 3-kinase—Akt—p70S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cellsJournal of Neurosurgery, 2002
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptorsBreast Cancer Research, 2000
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- The epidermal growth factor receptor is associated with phospholipase C-γ1 in meningiomasHuman Pathology, 1994
- Autocrine control of human meningioma proliferation: Secretion of platelet-derived growth-factor-like moleculesInternational Journal of Cancer, 1991
- Structural Characterization and Biological Functions of Fibroblast Growth FactorEndocrine Reviews, 1987